SCD and melanoma: In yet another study, the influence of differential lipid metabolism on therapeutic resistance in 2-D and 3-D systems was determined using GC–MS; the results demonstrated a significant correlation between the expression of stearoyl-CoA-desaturase (SCD1) and the progression of BRAF-mutated melanoma.